Quick Summary

Evening primrose (Oenothera biennis) is a plant whose oil, rich in gamma-linolenic acid (GLA), has been studied for various health conditions including menopausal symptoms, inflammatory diseases, mastalgia, and skin conditions such as atopic dermatitis. Clinical evidence is mixed, with some trials showing modest benefits and others showing no significant effect. Safety profiles generally indicate mild adverse effects, but comprehensive safety data especially for long-term use and during pregnancy are lacking. More high-quality research is needed to confirm efficacy and safety.

What is it

Evening primrose is a biennial plant native to North America, known scientifically as Oenothera biennis. Its seeds are used to produce evening primrose oil, which contains gamma-linolenic acid (GLA)—an omega-6 fatty acid thought to influence inflammatory processes. The oil is available as a dietary supplement in capsules and is used for various traditional and medicinal purposes.

Traditional Uses

  • Management of menopausal symptoms including hot flashes.
  • Support for inflammatory conditions such as rheumatoid arthritis and eczema.
  • Relief from mastalgia (breast pain).
  • Improvement of skin conditions like atopic dermatitis.
  • Assisting cervical ripening during labor.

Active Compounds

The primary active compound in evening primrose oil is gamma-linolenic acid (GLA), an omega-6 fatty acid. It may influence inflammatory pathways and skin barrier functions. Other fatty acids and phytochemicals may also contribute to its effects, but GLA is considered the main bioactive constituent.

Potential Benefits with Evidence Levels

  • Menopausal symptoms (hot flashes) — Moderate to low quality evidence: Some systematic reviews and meta-analyses of randomized controlled trials suggest evening primrose oil may reduce hot flash duration, but effects on frequency and severity are inconsistent or non-significant. Further well-designed studies are needed.
  • Inflammatory diseases — Insufficient and heterogeneous evidence: Clinical trials indicate potential benefits on rheumatoid arthritis, diabetes mellitus, atopic eczema, menopausal hot flashes, and mastalgia, but overall evidence is mixed and not strong enough for recommendations.
  • Mastalgia (breast pain) — Moderate quality evidence: Meta-analyses found no significant benefit over placebo or other treatments; it appears safe but not clearly more effective.
  • Atopic dermatitis and skin hydration — Low quality evidence: Oral evening primrose oil has not shown significant improvement in eczema symptoms compared to placebo, though some studies report possible enhancement in skin hydration and barrier function.
  • Induced abortion (with misoprostol) — Single randomized controlled trial: Vaginal evening primrose oil with misoprostol reduced fetal expulsion time, pain intensity, and misoprostol dose in women undergoing abortion for intrauterine fetal death.
  • Cervical ripening during labor — Moderate quality evidence: Meta-analyses show evening primrose oil significantly improved cervical ripening scores compared to placebo in term and post-term pregnant women.
  • Lipid profile — Limited RCT evidence: Supplementation (≤4 grams/day) may reduce triglycerides and increase HDL cholesterol in hyperlipidemic individuals.
  • Pruritus (itching) in atopic dermatitis — Insufficient evidence: Some preclinical and clinical studies suggest benefits, but data remain too limited to draw firm conclusions.

Side Effects

  • Mild nausea
  • Headache
  • Mild gastrointestinal symptoms
  • Potential increased bleeding risk when combined with anticoagulants (reported in some case reports)
  • No significant increase in adverse events compared to placebo in clinical trials

Drug Interactions

  • Possible increased bleeding risk when taken with anticoagulant medications such as warfarin, likely due to GLA content.
  • Limited evidence for other drug interactions; caution advised due to insufficient data.

Who Should Avoid It

There are no firmly established contraindications due to limited data. However, use during pregnancy and breastfeeding is generally not recommended pending further research. Individuals taking anticoagulant or antiplatelet medications should use caution and consult healthcare professionals before use. Medical supervision is advised if using during pregnancy or peripartum period.

Evidence Limitations

  • Many studies have small sample sizes and methodological limitations.
  • Heterogeneity in study designs, populations, dosages, and outcomes assessed.
  • Lack of long-term safety data and standardized herbal formulations.
  • Insufficient high-quality evidence to confirm efficacy for most indications.
  • Variable quality and inconsistency of outcome measures hinder comparability.

References

Last Reviewed

June 2024

Informational Disclaimer: This page is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting any new supplement, especially if you are pregnant, breastfeeding, have existing medical conditions, or are taking other medications.